Energy & environment · 18/09/2009Updated: 10/17/2026 · 1 min read
Johnson & Johnson's NJ Facility to Release Byproducts Without Environmental Review
Summary
The U.S. Environmental Protection Agency (EPA) has made available an environmental assessment and finding of no significant impact for a license amendment allowing Johnson & Johnson Pharmaceutical Research and Development, LLC to release byproducts from its Raritan, New Jersey facility without undergoing a full environmental review.